|
|
||||||||
Clinical Chemistry, Vol 40, 900-907, Copyright © 1994 by American Association for Clinical Chemistry
AH Wu, R Valdes Jr, FS Apple, T Gornet, MA Stone, S Mayfield-Stokes, AM Ingersoll-Stroubos and B Wiler
Department of Pathology, Hartford Hospital, CT.
We evaluated the analytical and clinical performance of an immunoassay for cardiac troponin T (cTnT). Within-run and total imprecision ranged from 1.6 to 11.3%. The sensitivity and linear range was 0.015 and 13 micrograms/L, respectively. Frozen samples were stable for at least 8 weeks. No interferences were seen with lipids or bilirubin (total and conjugated). Hemoglobin caused a negative bias at concentrations > 4 g/L. Heparinized plasma showed a 6% negative bias compared with serum. The clinical utility of cTnT was compared with that of creatine kinase (CK)-MB (mass assay). The sensitivity of cTnT measurements from 63 patients with acute myocardial infarction (AMI) (cTnT cutoff 0.1 microgram/L) was 60% at 0-3 h, 59% at 3-6 h, 94% at 6-9 h, 90% at 9-12 h, 99% at 12-24 h, 92% at 24-48 h, 83% at 48-72 h, and 100% at 72-96 h. Corresponding results for CK-MB (cutoff 5.0 micrograms/L and 2.5% relative index) were 45%, 64%, 82%, 97%, 87%, 81%, 54%, and 59%. The specificity of the markers from 49 non-AMI patients was 46% and 79% for cTnT and CK-MB, respectively. We show that CK-MB is more specific for diagnosis of AMI, and propose that cTnT is more sensitive to myocardial injury.
The following articles in journals at HighWire Press have cited this article:
![]() |
P O Collinson and D C Gaze Ischaemia-modified albumin: clinical utility and pitfalls in measurement J. Clin. Pathol., September 1, 2008; 61(9): 1025 - 1028. [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation, April 3, 2007; 115(13): e356 - e375. [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Clin. Chem., April 1, 2007; 53(4): 552 - 574. [Full Text] [PDF] |
||||
![]() |
R Sharma, D C Gaze, D Pellerin, R L Mehta, H Gregson, C P Streather, P O Collinson, and S J D Brecker Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T Heart, June 1, 2006; 92(6): 804 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharma, D. Pellerin, D.C. Gaze, J.S. Shah, C.P. Streather, P.O. Collinson, and S.J. Brecker Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates Eur J Echocardiogr, October 1, 2005; 6(5): 327 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease Circulation, December 3, 2002; 106(23): 2941 - 2945. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, R. C. Serfass, S. M. Mackey-Bojack, K. L. Kelly, J. L. Titus, and F. S. Apple Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise J Appl Physiol, May 1, 2000; 88(5): 1749 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. ver Elst, H. D. Spapen, D. N. Nguyen, C. Garbar, L. P. Huyghens, and F. K. Gorus Cardiac Troponins I and T Are Biological Markers of Left Ventricular Dysfunction in Septic Shock Clin. Chem., May 1, 2000; 46(5): 650 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morrow, N. Rifai, M. J. Tanasijevic, D. R. Wybenga, J. A. de Lemos, and E. M. Antman Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy Clin. Chem., April 1, 2000; 46(4): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Lund, J.K French, R.N Johnson, B.F Williams, and H.D White Serum troponins T and I after elective cardioversion Eur. Heart J., February 1, 2000; 21(3): 245 - 253. [Abstract] [PDF] |
||||
![]() |
E. I. Lev, J. I. Osende, A. G. Zaman, C. W. Hamm, and C. Heeschen Troponin T Levels and Abciximab Therapy in Unstable Angina N. Engl. J. Med., September 30, 1999; 341(14): 1084 - 1085. [Full Text] |
||||
![]() |
A. H.B. Wu, F. S. Apple, W. B. Gibler, R. L. Jesse, M. M. Warshaw, and R. Valdes Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases Clin. Chem., July 1, 1999; 45(7): 1104 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple Another reader comments on the same article: Clin. Chem., August 1, 1998; 44(8): 1786 - 1787. [Full Text] |
||||
![]() |
L. Coudrey The Troponins Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180. [Full Text] [PDF] |
||||
![]() |
M. Carrier, L. C. Pelletier, R. Martineau, M. Pellerin, and B. C. Solymoss In elective coronary artery bypass grafting, preoperative troponin T level predicts the risk of myocardial infarction J. Thorac. Cardiovasc. Surg., June 1, 1998; 115(6): 1328 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. B. Wu, Y.-J. Feng, R. Moore, F. S. Apple, P. H. McPherson, K. F. Buechler, G. Bodor, f. t. A. A. for, and C. C. S. o. c. Standardization Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I Clin. Chem., June 1, 1998; 44(6): 1198 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Christenson, S.-H. Duh, L. K. Newby, E. M. Ohman, R. M. Califf, C. B. Granger, S. Peck, K. S. Pieper, P. W. Armstrong, H. A. Katus, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes Clin. Chem., March 1, 1998; 44(3): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Toss, B. Lindahl, A. Siegbahn, L. Wallentin, and f. t. F. S. Group Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease Circulation, December 16, 1997; 96(12): 4204 - 4210. [Abstract] [Full Text] |
||||
![]() |
H. Baum, S. Braun, W. Gerhardt, G. Gilson, G. Hafner, M. Muller-Bardorff, W. Stein, G. Klein, C. Ebert, K. Hallermayer, et al. Multicenter evaluation of a second-generation assay for cardiac troponin T Clin. Chem., October 1, 1997; 43(10): 1877 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. B. Wu, Y.-J. Feng, J. Nadelman, M. Acampora, and P. N. Fiedler Ectopic Production of Creatine Kinase MB: Updated Evaluation by Mass Assays Clin. Chem., October 1, 1997; 43(10): 2006 - 2007. [Full Text] [PDF] |
||||
![]() |
M. Muller-Bardorff, K. Hallermayer, A. Schroder, C. Ebert, A. Borgya, W. Gerhardt, A. Remppis, J. Zehelein, and H. A. Katus Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation Clin. Chem., March 1, 1997; 43(3): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishikawa, J. E. Saffitz, T. L. Mealman, A. M. Grace, and R. Roberts Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma Clin. Chem., March 1, 1997; 43(3): 467 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. B. Wu, Y.-J. Feng, L. Roper, K. Herbert, and R. Schweizer Cardiac Troponins T and I Before and After Renal Transplantation Clin. Chem., February 1, 1997; 43(2): 411a - 412. [Full Text] |
||||
![]() |
E. M. Ohman, P. W. Armstrong, R. H. Christenson, C. B. Granger, H. A. Katus, C. W. Hamm, M. A. O'Hanesian, G. S. Wagner, N. S. Kleiman, F. E. Harrell, et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia N. Engl. J. Med., October 31, 1996; 335(18): 1333 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stubbs, P. Collinson, D. Moseley, T. Greenwood, and M. Noble Prognostic Significance of Admission Troponin T Concentrations in Patients With Myocardial Infarction Circulation, September 15, 1996; 94(6): 1291 - 1297. [Abstract] [Full Text] |
||||
![]() |
A. B. Eisenbrey and J. D. Artiss Cardiac Troponin T and Point-of-Care Testing for Myocardial Infarction JAMA, November 1, 1995; 274(17): 1343 - 1344. [Abstract] [PDF] |
||||
![]() |
E. M. Antman, C. Grudzien, and D. B. Sacks Evaluation of a Rapid Bedside Assay for Detection of Serum Cardiac Troponin T JAMA, April 26, 1995; 273(16): 1279 - 1282. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |